• SENSEX
    NIFTY 50

US FDA red flags emergency use nod for Covaxin; Bharat Biotech to seek full approval now

Updated : June 11, 2021 16:57:57 IST

The US FDA has asked the company to launch an additional trial, after which it can file for a Biologics Licence Application (BLA)
BLA is filed to get full approval for a vaccine
Ocugen, the company’s US partner, will now seek a full approval of Covaxin
US FDA red flags emergency use nod for Covaxin; Bharat Biotech to seek full approval now
Published : June 11, 2021 04:56 PM IST

You May Also Like

Live TV

recommended for you

Advertisement